Blossomhill Therapeutics, Inc. (BLSM)

26.80 +1.06 (+4.12%) USD  |  NASDAQ  |  Sep 21, 16:00
26.13 -0.67 (-2.50%) After-Hours: 20:00
More

Blossomhill Therapeutics EPS Diluted (Quarterly) : -0.7475 for June 30, 2026

EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for BLSM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2025. Start Trial.
Date Value
June 30, 2026 -0.7475
March 31, 2026 -0.6609
Date Value
June 30, 2025 -0.4167
March 31, 2025 -0.3296

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
IGC Pharma, Inc. -0.0293
Cocrystal Pharma, Inc. -0.2295
CNBX Pharmaceuticals, Inc. -0.0001
GB Sciences, Inc. --
Arvinas, Inc. 2.578

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -23.76M
Total Expenses (Quarterly) 23.76M
Enterprise Value 1.037B
Earnings Yield -8.04%
Normalized Earnings Yield -8.040